316 related articles for article (PubMed ID: 11170287)
21. Common fragile sites and cancer (review).
Smith DI; Huang H; Wang L
Int J Oncol; 1998 Jan; 12(1):187-96. PubMed ID: 9454904
[TBL] [Abstract][Full Text] [Related]
22. Roles of FHIT and WWOX fragile genes in cancer.
Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
[TBL] [Abstract][Full Text] [Related]
23. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type.
Muller CY; O'Boyle JD; Fong KM; Wistuba II; Biesterveld E; Ahmadian M; Miller DS; Gazdar AF; Minna JD
J Natl Cancer Inst; 1998 Mar; 90(6):433-9. PubMed ID: 9521167
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
Genes Chromosomes Cancer; 1997 Sep; 20(1):98-102. PubMed ID: 9290961
[TBL] [Abstract][Full Text] [Related]
25. Replication stress induces tumor-like microdeletions in FHIT/FRA3B.
Durkin SG; Ragland RL; Arlt MF; Mulle JG; Warren ST; Glover TW
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):246-51. PubMed ID: 18162546
[TBL] [Abstract][Full Text] [Related]
26. Common chromosomal fragile sites and cancer: focus on FRA16D.
O'Keefe LV; Richards RI
Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
[TBL] [Abstract][Full Text] [Related]
27. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE
Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215
[TBL] [Abstract][Full Text] [Related]
28. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.
Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR
Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423
[TBL] [Abstract][Full Text] [Related]
29. An FHIT tumor suppressor gene?
Le Beau MM; Drabkin H; Glover TW; Gemmill R; Rassool FV; McKeithan TW; Smith DI
Genes Chromosomes Cancer; 1998 Apr; 21(4):281-9. PubMed ID: 9559339
[TBL] [Abstract][Full Text] [Related]
30. Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors.
Shridhar R; Shridhar V; Wang X; Paradee W; Dugan M; Sarkar F; Wilke C; Glover TW; Vaitkevicius VK; Smith DI
Cancer Res; 1996 Oct; 56(19):4347-50. PubMed ID: 8813121
[TBL] [Abstract][Full Text] [Related]
31. Allele-specific late replication and fragility of the most active common fragile site, FRA3B.
Wang L; Darling J; Zhang JS; Huang H; Liu W; Smith DI
Hum Mol Genet; 1999 Mar; 8(3):431-7. PubMed ID: 9949202
[TBL] [Abstract][Full Text] [Related]
32. Direct correlation between FRA3B expression and cigarette smoking.
Stein CK; Glover TW; Palmer JL; Glisson BS
Genes Chromosomes Cancer; 2002 Jul; 34(3):333-40. PubMed ID: 12007194
[TBL] [Abstract][Full Text] [Related]
33. A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints.
Paradee W; Wilke CM; Wang L; Shridhar R; Mullins CM; Hoge A; Glover TW; Smith DI
Genomics; 1996 Jul; 35(1):87-93. PubMed ID: 8661108
[TBL] [Abstract][Full Text] [Related]
34. Evidence that instability within the FRA3B region extends four megabases.
Becker NA; Thorland EC; Denison SR; Phillips LA; Smith DI
Oncogene; 2002 Dec; 21(57):8713-22. PubMed ID: 12483524
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation.
Kato T; Franconi CP; Sheridan MB; Hacker AM; Inagakai H; Glover TW; Arlt MF; Drabkin HA; Gemmill RM; Kurahashi H; Emanuel BS
Cancer Genet; 2014 Apr; 207(4):133-40. PubMed ID: 24813807
[TBL] [Abstract][Full Text] [Related]
36. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B.
Mimori K; Druck T; Inoue H; Alder H; Berk L; Mori M; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7456-61. PubMed ID: 10377436
[TBL] [Abstract][Full Text] [Related]
37. Anomalous transcripts and allelic deletions of the FHIT gene in human esophageal cancer.
Menin C; Santacatterina M; Zambon A; Montagna M; Parenti A; Ruol A; D'Andrea E
Cancer Genet Cytogenet; 2000 May; 119(1):56-61. PubMed ID: 10812172
[TBL] [Abstract][Full Text] [Related]
38. Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit.
Shiraishi T; Druck T; Mimori K; Flomenberg J; Berk L; Alder H; Miller W; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2001 May; 98(10):5722-7. PubMed ID: 11320209
[TBL] [Abstract][Full Text] [Related]
39. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region.
van den Berg A; Draaijers TG; Kok K; Timmer T; Van der Veen AY; Veldhuis PM; de Leij L; Gerhartz CD; Naylor SL; Smith DI; Buys CH
Genes Chromosomes Cancer; 1997 Aug; 19(4):220-7. PubMed ID: 9258656
[TBL] [Abstract][Full Text] [Related]
40. Chromosome arm 8p and cancer: a fragile hypothesis.
Birnbaum D; Adélaïde J; Popovici C; Charafe-Jauffret E; Mozziconacci MJ; Chaffanet M
Lancet Oncol; 2003 Oct; 4(10):639-42. PubMed ID: 14554243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
